|
Transplantation
Citations 71-80 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease
- Paul J. Martin, Barry E. Storer, Scott D. Rowley, Mary E. D. Flowers, Stephanie J. Lee, Paul A. Carpenter, John R. Wingard, Paul J. Shaughnessy, Marcel P. DeVetten, Madan Jagasia, Joseph W. Fay, Koen van Besien, Vikas Gupta, Carrie Kitko, Laura J. Johnston, Richard T. Maziarz, Mukta Arora, Pamala A. Jacobson, and Daniel Weisdorf
Blood 2009; 113: 5074-5082.
[Abstract]
[Full text]
[PDF]
Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipients
- Brian C. Beard, Reeteka Sud, Kirsten A. Keyser, Christina Ironside, Tobias Neff, Sabine Gerull, Grant D. Trobridge, and Hans-Peter Kiem
Blood 2009; 113: 5094-5103.
[Abstract]
[Full text]
[PDF]
Induction of type I IFN is required for overcoming tumor-specific T-cell tolerance after stem cell transplantation
- Ian Horkheimer, Michael Quigley, Jiangao Zhu, Xiaopei Huang, Nelson J. Chao, and Yiping Yang
Blood 2009; 113: 5330-5339.
[Abstract]
[Full text]
[PDF]
Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity
- Benjamin J. Capoccia, Debra L. Robson, Krysta D. Levac, Dustin J. Maxwell, Sarah A. Hohm, Marian J. Neelamkavil, Gillian I. Bell, Anargyros Xenocostas, Daniel C. Link, David Piwnica-Worms, Jan A. Nolta, and David A. Hess
Blood 2009; 113: 5340-5351.
[Abstract]
[Full text]
[PDF]
Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement
- Zhengqi Wang, Geqiang Li, William Tse, and Kevin D. Bunting
Blood 2009; 113: 4856-4865.
[Abstract]
[Full text]
[PDF]
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
- Ola Landgren, Ethel S. Gilbert, J. Douglas Rizzo, Gérard Socié, Peter M. Banks, Kathleen A. Sobocinski, Mary M. Horowitz, Elaine S. Jaffe, Douglas W. Kingma, Lois B. Travis, Mary E. Flowers, Paul J. Martin, H. Joachim Deeg, and Rochelle E. Curtis
Blood 2009; 113: 4992-5001.
[Abstract]
[Full text]
[PDF]
Bone marrow deficient in IFN- signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect
- Christian M. Capitini, Sarah Herby, Matthew Milliron, Miriam R. Anver, Crystal L. Mackall, and Terry J. Fry
Blood 2009; 113: 5002-5009.
[Abstract]
[Full text]
[PDF]
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery
- Anna Dodero, Cristiana Carniti, Anna Raganato, Antonio Vendramin, Lucia Farina, Francesco Spina, Carmelo Carlo-Stella, Simona Di Terlizzi, Marco Milanesi, Paolo Longoni, Lorenza Gandola, Claudia Lombardo, and Paolo Corradini
Blood 2009; 113: 4771-4779.
[Abstract]
[Full text]
[PDF]
Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease
- Kaori Sato, Kawori Eizumi, Tomohiro Fukaya, Shigeharu Fujita, Yumiko Sato, Hideaki Takagi, Mai Yamamoto, Naohide Yamashita, Atsushi Hijikata, Hiroshi Kitamura, Osamu Ohara, Sho Yamasaki, Takashi Saito, and Katsuaki Sato
Blood 2009; 113: 4780-4789.
[Abstract]
[Full text]
[PDF]
Polyclonal T-cell reconstitution of X-SCID recipients after in utero transplantation of lymphoid-primed multipotent progenitors
- Karina Liuba, Cornelis J. H. Pronk, Simon R. W. Stott, and Sten-Eirik W. Jacobsen
Blood 2009; 113: 4790-4798.
[Abstract]
[Full text]
[PDF]
|
|
